News & Events
Monday, 18 August 2005
PEAKDALE
ANNOUNCES APPOINTMENT OF INDUSTRY FIGUREHEAD AS MEDICINAL
CHEMISTRY SERVICES DIRECTOR
Peakdale Molecular Ltd announces the appointment of Dr
Terry Hart to the Company’s Board of Directors in
order to drive further Medicinal Chemistry capabilities
and enhance
their range of services.
Terry brings a wealth of medicinal chemistry knowledge to Peakdale, with an industry pedigree of over 20 years of pharmaceutical experience. This new role has been created to add further value to customers’ drug discovery activities and, as Medicinal Chemistry Services Director, Terry will apply the latest medicinal chemistry knowledge and his extensive drug discovery experience to further support pharmaceutical and biotech customers’ drive for new drugs.
Terry joins Peakdale from the Novartis Institute for Biomedical Research where he was Unit Head of Discovery Chemistry for 7 years. While there he co-invented several compounds that are currently in clinical trials for pain, anxiety and depression. He has previous experience as Director of Medicinal Chemistry within the Biotech industry where he invented RAPiD (Rational Approach to Protease Inhibitor Design), a patented, combinatorial mapping and protease inhibitor design technology. Prior to this position, Terry spent 17 years at Rhône-Poulenc Rorer, in both the UK and France, where he designed and synthesised several clinical candidates, was programme leader for the Taxotere programme, and became Chemistry Programme Director, Cardiovascular Research.
Terry added, "I’m looking forward to joining Peakdale at such an exciting time. I have long looked upon the Company as a top provider of chemistry innovation. I intend to significantly develop Peakdale’s medicinal chemistry capabilities and offer additional value to Peakdale’s clients."
For
more information please contact:
At the Company
Glenn Killingworth, Business Development Manager
+44 (0)1298 816700
glenn.killingworth@peakdale.co.uk
On
behalf of the Company
Marc Egelhofer, Northbank Communications
+44 (0)1260 296500
m.egelhofer@northbankcommunications.com